Top Markets
#1 Black Phoenix Black Phoenix +823.46%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.62%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.43%
#4 Beam Beam +24.43%
#5 Tutorial Tutorial +24.41%
#6 Bless Bless +19.73%
#7 SAFEcoin SAFEcoin +18.55%
#8 Magma Finance Magma Finance +17.14%
#9 MiL.k Alliance MiL.k Alliance +16.48%
#10 THORChain THORChain +16.18%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
Rank in Stocks #5730
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
Share Price
$29.86
Last synced: 2026-08-19
Market Cap
$2.48B
Change (1 day)
4.92%
Change (1 year)
502.82%
Country
TW
Trade Lin BioScience, Inc. (6696)

Category

Healthcare
Earnings for Lin BioScience, Inc. (6696)
Earnings in 2026 TTM: 0
According to Lin BioScience, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Lin BioScience, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH